 |
0 Diseases |  |
33 Trials |
|
33 Trials |  |
2235 News |  |
| «12...25262728293031323334353637» |
- | OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
New P4 trial: OSDI: Oral Sedation During Cervical Dilator Placement (clinicaltrials.gov) - Jun 27, 2017
P4, N=60, Not yet recruiting, Sponsor: Johns Hopkins University
- | lorazepam / Generic mfg.
New P2 trial: Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy: (clinicaltrials.gov) - Jun 7, 2017
P2, N=96, Not yet recruiting, Sponsor: St. Justine's Hospital
- | lorazepam / Generic mfg., midazolam hydrochloride / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: HYPNOS: How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units (clinicaltrials.gov) - Jun 4, 2017
P1, N=6, Terminated, Sponsor: Vanderbilt University Medical Center
Phase classification: P=N/A --> P1 | N=30 --> 6 | Active, not recruiting --> Terminated; poor recruitment
- | ketamine / Generic mfg.
Trial primary completion date: Treatment Resistant Depression (Pilot) (clinicaltrials.gov) - May 30, 2017
P=N/A, N=40, Recruiting, Sponsor: Washington University School of Medicine
Phase classification: P=N/A --> P1 | N=30 --> 6 | Active, not recruiting --> Terminated; poor recruitment Trial primary completion date: Jun 2016 --> Jun 2018
- | lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
Trial initiation date: Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) - May 16, 2017
P1, N=480, Not yet recruiting, Sponsor: McMaster University
Trial primary completion date: Jun 2016 --> Jun 2018 Initiation date: May 2017 --> Sep 2017
- | lorazepam / Generic mfg., ibuprofen / Generic mfg.
Trial primary completion date: Analgesia for Endometrial Scratching (clinicaltrials.gov) - May 9, 2017
P=N/A, N=150, Enrolling by invitation, Sponsor: University of Sao Paulo
Initiation date: May 2017 --> Sep 2017 Trial primary completion date: Mar 2017 --> Sep 2017
- | Recentin (cediranib) / AstraZeneca
Trial primary completion date, Monotherapy, Metastases: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) - May 4, 2017
P2, N=70, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Mar 2017 --> Sep 2017 Trial primary completion date: Apr 2017 --> Apr 2018
- | lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Apr 18, 2017
P4, N=49, Terminated, Sponsor: Denver Health and Hospital Authority
Trial primary completion date: Apr 2017 --> Apr 2018 Trial primary completion date: Mar 2017 --> Dec 2015
- | Adasuve (staccato loxapine) / AOP Orphan Pharma, Teva, Ferrer International, Galen, Medivir
New P4 trial, Head-to-Head: Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation (clinicaltrials.gov) - Apr 12, 2017
P4, N=140, Not yet recruiting, Sponsor: University of Arkansas
- | lorazepam / Generic mfg., haloperidol / Generic mfg.
Trial primary completion date, Metastases: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) - Mar 30, 2017
P2, N=93, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Mar 2017 --> Dec 2015 Trial primary completion date: Jan 2018 --> Jan 2019
- | lorazepam / Generic mfg.
New P4 trial: TAAT: Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome (clinicaltrials.gov) - Mar 27, 2017
P4, N=28, Recruiting, Sponsor: University of Colorado, Denver
- darigabat (CVL-865) / Cerevel Therap
Trial completion: PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) - Mar 14, 2017
P2, N=7, Completed, Sponsor: Pfizer
Trial primary completion date: Jan 2018 --> Jan 2019 Recruiting --> Completed
- | gabapentin / Generic mfg.
Enrollment open: Gabapentin for Alcohol Withdrawal Syndrome (clinicaltrials.gov) - Feb 16, 2017
P4, N=400, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Completed Not yet recruiting --> Recruiting
- lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
New P1 trial: Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) - Feb 15, 2017
P1, N=480, Not yet recruiting, Sponsor: McMaster University
- |||| brivaracetam / Generic mfg.
Enrollment open: A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting (clinicaltrials.gov) - Feb 11, 2017
P2, N=60, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| brivaracetam / Generic mfg.
New P2 trial: A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting (clinicaltrials.gov) - Jan 13, 2017
P2, N=60, Not yet recruiting, Sponsor: UCB Biopharma S.P.R.L.
- | gabapentin / Generic mfg.
New P4 trial: Gabapentin for Alcohol Withdrawal Syndrome (clinicaltrials.gov) - Jan 5, 2017
P4, N=400, Not yet recruiting, Sponsor: Mayo Clinic
- Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
Trial completion: Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) - Dec 14, 2016
P=N/A, N=625, Completed, Sponsor: James K. Rilling, PhD
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- clonazepam / Generic mfg., lorazepam / Generic mfg., fosphenytoin / Generic mfg.
Trial primary completion date: LORACLOFT: Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus (clinicaltrials.gov) - Dec 13, 2016
P3, N=522, Recruiting, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Jun 2017
- lorazepam / Generic mfg., venlafaxine extended release / Generic mfg.
Trial completion: MEDEX: A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise (clinicaltrials.gov) - Dec 12, 2016
P=N/A, N=31, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: Jun 2015 --> Jun 2017 Recruiting --> Completed
- || lorazepam / Generic mfg.
Trial completion, Trial primary completion date: Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan (clinicaltrials.gov) - Nov 21, 2016
P3, N=26, Completed, Sponsor: Pfizer
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Apr 2017 --> Aug 2016
- Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
Enrollment closed: Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) - Nov 15, 2016
P1, N=109, Active, not recruiting, Sponsor: University of Florida
Recruiting --> Completed | Trial primary completion date: Apr 2017 --> Aug 2016 Recruiting --> Active, not recruiting
- lorazepam / Generic mfg.
Trial completion: The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms (clinicaltrials.gov) - Nov 10, 2016
P1, N=57, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- New trial: Assessment of Peripheral GABA Receptors for Local Pain Relief (clinicaltrials.gov) - Oct 11, 2016
P=N/A, N=90, Recruiting, Sponsor: Aalborg University
- Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
Enrollment closed: Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) - Oct 10, 2016
P=N/A, N=750, Active, not recruiting, Sponsor: James K. Rilling, PhD
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- lorazepam / Generic mfg., venlafaxine extended release / Generic mfg.
Trial primary completion date: MEDEX: A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise (clinicaltrials.gov) - Oct 3, 2016
P=N/A, N=30, Recruiting, Sponsor: University of Pittsburgh
Enrolling by invitation --> Active, not recruiting Trial primary completion date: Oct 2016 --> Jan 2017
- lorazepam / Generic mfg., haloperidol / Generic mfg.
Enrollment closed, Enrollment change, Metastases: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) - Sep 16, 2016
P2, N=93, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Oct 2016 --> Jan 2017 Recruiting --> Active, not recruiting | N=60 --> 93
- lorazepam / Generic mfg., topiramate / Generic mfg.
Trial completion, Trial primary completion date: Characterizing and Predicting Drug Effects on Cognition (clinicaltrials.gov) - Sep 15, 2016
P4, N=78, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Active, not recruiting | N=60 --> 93 Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2016
- ondansetron intravenous / Generic mfg., lorazepam / Generic mfg., diazepam / Generic mfg.
Trial completion, Trial primary completion date: Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients (clinicaltrials.gov) - Sep 8, 2016
P=N/A, N=26, Completed, Sponsor: Lehigh Valley Hospital
Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2016 Enrolling by invitation --> Completed | Trial primary completion date: Mar 2013 --> Dec 2010
- lorazepam / Generic mfg., venlafaxine extended release / Generic mfg.
Trial primary completion date: MEDEX: A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise (clinicaltrials.gov) - Aug 16, 2016
P=N/A, N=30, Recruiting, Sponsor: University of Pittsburgh
Enrolling by invitation --> Completed | Trial primary completion date: Mar 2013 --> Dec 2010 Trial primary completion date: Apr 2016 --> Oct 2016
- lorazepam / Generic mfg., ibuprofen / Generic mfg.
New trial: Analgesia for Endometrial Scratching (clinicaltrials.gov) - Aug 11, 2016
P=N/A, N=150, Enrolling by invitation, Sponsor: University of Sao Paulo
- lorazepam / Generic mfg.
Enrollment closed, Enrollment change: The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms (clinicaltrials.gov) - Aug 1, 2016
P1, N=57, Active, not recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Apr 2016 --> Oct 2016 Recruiting --> Active, not recruiting | N=75 --> 57
- || lorazepam / Generic mfg.
Trial completion: Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly (clinicaltrials.gov) - Jul 28, 2016
P3, N=31, Completed, Sponsor: Biocodex
Recruiting --> Active, not recruiting | N=75 --> 57 Recruiting --> Completed
- Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
Trial primary completion date: Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=750, Enrolling by invitation, Sponsor: James K. Rilling, PhD
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Sep 2016
- | lorazepam / Generic mfg.
Trial primary completion date: Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan (clinicaltrials.gov) - May 31, 2016
P3, N=25, Recruiting, Sponsor: Pfizer
Trial primary completion date: Jun 2016 --> Sep 2016 Trial primary completion date: Jul 2016 --> Apr 2017
- ||| lorazepam / Generic mfg.
Trial completion: Lorazepam for the Treatment of Status Epilepticus in Children (clinicaltrials.gov) - May 21, 2016
P1, N=69, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Trial primary completion date: Jul 2016 --> Apr 2017 Recruiting --> Completed
- ||||||| lorazepam / Generic mfg., midazolam hydrochloride / Generic mfg.
Trial completion: Lorazepam Sedation for Critically Ill Children (clinicaltrials.gov) - May 21, 2016
P2/3, N=179, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed Suspended --> Completed
- | lorazepam / Generic mfg.
Trial primary completion date: Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan (clinicaltrials.gov) - May 18, 2016
P3, N=25, Recruiting, Sponsor: Pfizer
Suspended --> Completed Trial primary completion date: Apr 2016 --> Jul 2016
- lorazepam / Generic mfg.
Trial withdrawal: GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 (clinicaltrials.gov) - May 13, 2016
P1/2, N=0, Withdrawn, Sponsor: University of California, Los Angeles
Trial primary completion date: Apr 2016 --> Jul 2016 Terminated --> Withdrawn
- lorazepam / Generic mfg.
Enrollment change: Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest (clinicaltrials.gov) - Mar 29, 2016
P4, N=30, Recruiting, Sponsor: Far Eastern Memorial Hospital
Terminated --> Withdrawn N=200 --> 30
- Recentin (cediranib) / AstraZeneca
Trial primary completion date, Monotherapy, Metastases: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) - Mar 5, 2016
P2, N=70, Recruiting, Sponsor: National Cancer Institute (NCI)
N=200 --> 30 Trial primary completion date: Apr 2016 --> Apr 2017
- darigabat (CVL-865) / Cerevel Therap
Trial primary completion date: PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) - Feb 23, 2016
P2, N=8, Recruiting, Sponsor: Pfizer
Trial primary completion date: Apr 2016 --> Apr 2017 Trial primary completion date: Jul 2016 --> Nov 2016
- lorazepam / Generic mfg., haloperidol / Generic mfg.
Enrollment change, Trial primary completion date, Metastases: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) - Feb 17, 2016
P2, N=60, Recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jul 2016 --> Nov 2016 N=34 --> 60 | Trial primary completion date: Jan 2017 --> Jan 2018
- darigabat (CVL-865) / Cerevel Therap
Enrollment open: PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) - Feb 12, 2016
P2, N=8, Recruiting, Sponsor: Pfizer
N=34 --> 60 | Trial primary completion date: Jan 2017 --> Jan 2018 Not yet recruiting --> Recruiting
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - Feb 9, 2016
P4, N=49, Terminated, Sponsor: Denver Health and Hospital Authority
Not yet recruiting --> Recruiting N=150 --> 49 | Recruiting --> Terminated; DSMB recommendation for slow enrollment
- Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
Trial primary completion date: Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) - Jan 30, 2016
P1, N=100, Recruiting, Sponsor: University of Florida
N=150 --> 49 | Recruiting --> Terminated; DSMB recommendation for slow enrollment Trial primary completion date: Apr 2016 --> Apr 2017
- lorazepam / Generic mfg.
Trial primary completion date: The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms (clinicaltrials.gov) - Jan 17, 2016
P1, N=75, Recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Apr 2016 --> Apr 2017 Trial primary completion date: Oct 2015 --> Sep 2016
- ketamine / Generic mfg.
Trial primary completion date: Treatment Resistant Depression (Pilot) (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=40, Recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Oct 2015 --> Sep 2016 Trial primary completion date: Dec 2015 --> Jun 2016
- darigabat (CVL-865) / Cerevel Therap
New P2 trial: PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) - Sep 30, 2015
P2, N=8, Not yet recruiting, Sponsor: Pfizer
- | Gralise (gabapentin) / Alvogen
Enrollment closed, Trial primary completion date: Stanford Accelerated Recovery Trial (START) (clinicaltrials.gov) - Aug 26, 2015
P3, N=560, Active, not recruiting, Sponsor: Stanford University
Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Jul 2016